DATASHEET
Host:
Rabbit
Target Protein:
CD276/B7H3
Immunogen Range:
101-200/534
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
80381
Swiss Prot:
Q5ZPR3
Source:
KLH conjugated synthetic peptide derived from human CD276/B7H3
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling.
PRODUCT SPECIFIC PUBLICATIONS
- Nan Cheng. et al. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy. Biochem Pharmacol. 2021 Jan;183:114298Read more>>
VALIDATION IMAGES
Formalin-fixed and paraffin embedded human laryngeal carcinoma labeled with Rabbit Anti-CD276/B7H3 Polyclonal Antibody, Unconjugated (bs-11019R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Lane 1:JAR cell lysates;Lane 2: MCF-7 cell lysates probed with CD276 Polyclonal Antibody, Unconjugated (bs-11019R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.